ChiCTR1900024687 版本V1.0 版本创建时间2019/09/12 11:07:28 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR1900024687 

最近更新日期:

Date of Last Refreshed on:

2019-07-21 16:58:09 

注册时间:

Date of Registration:

2019-07-21 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

杨永圣医师: 该研究尚未获得伦理委员会批准。请于批准后再开始纳入参试者,并与我们联系上传批件。 创伤疼痛及干预对伤后早期创伤后应激障碍发病影响的研究

Public title:

A study for the effect of traumatic pain and intervention on the incidence of early post-traumatic stress disorder

注册题目简写:

English Acronym:

研究课题的正式科学名称:

创伤疼痛及干预对伤后早期创伤后应激障碍发病影响的研究

Scientific title:

A study for the effect of traumatic pain and intervention on the incidence of early post-traumatic stress disorder

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

杨永圣 

研究负责人:

许铁 

Applicant:

Yang Yongsheng 

Study leader:

Xu Tie 

申请注册联系人电话:

Applicant telephone:

+86 15050827413

研究负责人电话:

Study leader's telephone:

+86 18052268399

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

ys19910902@163.com

研究负责人电子邮件:

Study leader's E-mail:

xutie889@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

江苏省徐州市淮海西路99号

研究负责人通讯地址:

江苏省徐州市淮海西路99号

Applicant address:

99 Huaihai Road West, Xuzhou, Jiangsu, China

Study leader's address:

99 Huaihai Road West, Xuzhou, Jiangsu, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

徐州医科大学附属医院

Applicant's institution:

Affiliated Hospital of Xuzhou Medical University

研究负责人所在单位:

徐州医科大学附属医院

Affiliation of the Leader:

Affiliated Hospital of Xuzhou Medical University

是否获伦理委员会批准:

否/No

Approved by ethic committee:

No

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

徐州医科大学附属医院

Primary sponsor:

Affiliated Hospital of Xuzhou Medical University

研究实施负责(组长)单位地址:

江苏省徐州市淮海西路99号

Primary sponsor's address:

99 Huaihai Road West, Xuzhou, Jiangsu, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏省

市(区县):

徐州市

Country:

China

Province:

Jiangsu

City:

Xuzhou

单位(医院):

徐州医科大学附属医院

具体地址:

淮海西路99号

Institution
hospital:

Affiliated Hospital of Xuzhou Medical University

Address:

99 Huaihai Road West

经费或物资来源:

国家自然科学基金(H1504)

Source(s) of funding:

National Natural Science Foundation of China (H1504)

Target disease:

Post-traumatic stress disorder(PTSD)

Target disease code:

研究类型:

基础科学研究

Study type:

Basic Science

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

析因分组(即根据危险因素或暴露因素分组) 

Study design:

Factorial 

研究目的:

探讨急性疼痛与PTSD之间的关系及疼痛干预对PTSD发病的影响。  

Objectives of Study:

To explore the relationship between acute pain and PTSD and the effect of pain intervention on the pathogenesis of PTSD.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1)年龄18周岁以上,同意加入本项研究者;
2)神志清楚,视觉正常,病情及生命体征平稳者;
3)1年内无其他重大应激性事件发生者;
4)能够有效完成问卷者。

Inclusion criteria

1) Aged 18 years or older, agreed to join the researcher;
2) clear mind, normal vision, stable condition and vital signs;
3) no other major stress events within one year;
4) those who can effectively complete the questionnaire.

排除标准:

1)严重脑器质性损伤及视物不清者;
2)重度精神创伤史(性侵害等)、精神疾病或精神发育迟滞者;
3)吸毒或药物成瘾者;
4)病情危重或情绪激动不能配合调查者;
5)中途退出研究者。

Exclusion criteria:

1) Severe organic brain injury and blurred vision;
2) Severe traumatic history (sexual assault, etc.), mental illness or mental retardation;
3) drug addicts or drug addicts;
4) critically ill or emotional agitation can not cooperate with investigators;
5) withdrawal from the researcher halfway.

研究实施时间:

Study execute time:

From 2019-07-01 00:00:00 To 2020-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2019-08-01 00:00:00 To 2020-06-30 00:00:00  

干预措施:

Interventions:

组别:

PTSD组与非PTSD组

样本量:

100

Group:

PTSD group and non-PTSD group

Sample size:

干预措施:

创伤临床常规治疗,无额外干预。

干预措施代码:

Intervention:

Trauma was treated routinely without additional intervention.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江苏省 

市(区县):

徐州市 

Country:

China 

Province:

Jiangsu 

City:

Xuzhou 

单位(医院):

徐州医科大学附属医院 

单位级别:

三级甲等 

Institution
hospital:

Affiliated Hospital of Xuzhou Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

PCL-5得分

指标类型:

主要指标

Outcome:

PCL-5 score

Type:

Primary indicator

测量时间点:

创伤后1个月

测量方法:

PCL-5量表

Measure time point of outcome:

One month after trauma

Measure method:

PCL-5 scale

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 70 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

未使用

Randomization Procedure (please state who generates the random number sequence and by what method):

not used

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

N/A

Blinding:

N/A

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

研究过程中公开原始数据,网络平台公开,网址:http://www.chictr.org.cn

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

In the course of the research, the original data is made public, the network platform is used, and the website is http://www.chictr.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

使用病例记录表收集数据,应用电子表格管理数据。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data were collected by using case records and managed by spreadsheet.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2019-07-21 16:58:09